APA (7th ed.) Citation

Hou, C., Hao, X., Sun, N., Luo, X., Gao, Z., Chen, L., . . . Qin, Z. (2023). Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis. Journal of cardiovascular pharmacology and therapeutics, 28, 10742484231219603. https://doi.org/10.1177/10742484231219603

Chicago Style (17th ed.) Citation

Hou, Changchun, Xinxin Hao, Ning Sun, Xiaolin Luo, Zhichun Gao, Ling Chen, Xi Liu, and Zhexue Qin. "Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis." Journal of Cardiovascular Pharmacology and Therapeutics 28 (2023): 10742484231219603. https://doi.org/10.1177/10742484231219603.

MLA (9th ed.) Citation

Hou, Changchun, et al. "Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis." Journal of Cardiovascular Pharmacology and Therapeutics, vol. 28, 2023, p. 10742484231219603, https://doi.org/10.1177/10742484231219603.